Skip to main navigation Skip to search Skip to main content

A Phase IIb, Multicenter, Open-label, Rollover Study Evaluating the Efficacy, Safety and Tolerability of Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months in HIV-1

University at Buffalo

Project: Research

Project Details

StatusFinished
Effective start/end date10/22/18 → 10/22/24

Funding

  • PPD Investigator Services LLC: $124,844.29